Lunai Bioworks Inc (LNAI)

Mar 05, 2026

Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com UK

Mar 05, 2026

Mar 05, 2026

Lunai Bioworks Furloughs Staff Amid Liquidity Constraints - TipRanks

Mar 05, 2026

Mar 05, 2026

Lunai Bioworks implements temporary furlough of employees in US and CanadaSEC filing - marketscreener.com

Mar 05, 2026

Mar 05, 2026

Lunai Bioworks implements temporary furloughs, execs defer salaries to preserve liquidity - TradingView

Mar 05, 2026

Mar 05, 2026

Financial Survey: Lunai Bioworks (NASDAQ:LNAI) versus Lite Strategy (NASDAQ:LITS) - Defense World

Mar 05, 2026

Mar 02, 2026

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - The Sheboygan Press

Mar 02, 2026

Feb 28, 2026

Lunai Bioworks Highlights Sentinel AI Safeguard After Anthropic CEO Warning on AI Chemical and Biological Threats - The Destin Log

Feb 28, 2026

Feb 27, 2026

LNAI Should I Buy - Intellectia AI

Feb 27, 2026

Feb 23, 2026

Lunai Bioworks Faces Nasdaq Delisting, Hearing Scheduled - TipRanks

Feb 23, 2026

Feb 23, 2026

Lunai Bioworks Received Notice of Delisting - TradingView

Feb 23, 2026

Feb 23, 2026

Head-To-Head Comparison: Lunai Bioworks (NASDAQ:LNAI) vs. NexImmune (OTCMKTS:NEXI) - Defense World

Feb 23, 2026

Feb 20, 2026

LNAI | Lunai Bioworks Inc. Common Institutional Ownership - Quiver Quantitative

Feb 20, 2026

Feb 20, 2026

LNAI | Lunai Bioworks Inc. Common Insider Trading - Quiver Quantitative

Feb 20, 2026

Feb 20, 2026

ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class ActionENOB - marketscreener.com

Feb 20, 2026

Feb 19, 2026

Lunai Bioworks Reports Q2 Loss - National Today

Feb 19, 2026

Feb 19, 2026

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping - Finviz

Feb 19, 2026

Feb 19, 2026

Lunai Bioworks Secures Foundational Patent to Strengthen AI Moat - Intellectia AI

Feb 19, 2026

Feb 18, 2026

Lunai Bioworks kicks off AI-driven oncology pilot to analyze phase 2 colorectal cancer trial - MSN

Feb 18, 2026

Feb 17, 2026

Lunai Bioworks: Second Quarter Financial Results Overview - Bitget

Feb 17, 2026

Feb 17, 2026

Lunai Bioworks: Fiscal Q2 Earnings Snapshot - marketscreener.com

Feb 17, 2026

Feb 17, 2026

Lunai Bioworks Inc. SEC 10-Q Report - TradingView

Feb 17, 2026

Feb 13, 2026

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC - Finviz

Feb 13, 2026

Feb 12, 2026

Lunai Bioworks Faces Nasdaq Delisting After Bid Price Breach - TipRanks

Feb 12, 2026

Feb 10, 2026

Lunai Bioworks Launches AI Oncology Pilot to Analyze Phase 2 Colorectal Cancer Trial Data - AIM Media House

Feb 10, 2026

Feb 09, 2026

Lunai Bioworks Updates Shareholders on February 2026 Operational Progress and Future Plans - geneonline.com

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks, Inc. Issues Letter to Shareholders - The Malaysian Reserve

Feb 09, 2026

Feb 09, 2026

LNAI Partners on Phase 2 Cancer Trial to Enhance Patient Outcomes - GuruFocus

Feb 09, 2026

Feb 09, 2026

LNAI Strengthens AI Platform for Biotech Innovations and Partner - GuruFocus

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data - Finviz

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks (Nasdaq LNAI) launches AI oncology pilot - marketscreener.com

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks (Nasdaq Lnai) Launches Ai Oncology Pilot - TradingView

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks launches AI analysis of colorectal cancer trial data - Investing.com

Feb 09, 2026

Feb 09, 2026

Lunai Bioworks Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data - marketscreener.com

Feb 09, 2026

Jan 27, 2026

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons - Finviz

Jan 27, 2026

Jan 27, 2026

Lunai Launches Sentinel AI Biosecurity Layer - Intellectia AI

Jan 27, 2026

Jan 27, 2026

AI safeguard Sentinel blocks novel chemical weapon designs at source - stocktitan.net

Jan 27, 2026

Jan 27, 2026

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery - The Malaysian Reserve

Jan 27, 2026

Jan 26, 2026

Lunai Bioworks launches alcohol use disorder drug discovery program By Investing.com - Investing.com Canada

Jan 26, 2026

Jan 26, 2026

Lunai Bioworks Expands NIH-Backed AI Platform Into Commercial Alcohol Use Disorder Drug Discovery - Nasdaq

Jan 26, 2026

Jan 26, 2026

LNAI Advances Drug Discovery Program for Alcohol Use Disorder - GuruFocus

Jan 26, 2026

Jan 26, 2026

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into - GuruFocus

Jan 26, 2026

Jan 26, 2026

Lunai Bioworks Launches Alcohol Use Disorder Program Following Key Milestones - Intellectia AI

Jan 26, 2026

Jan 14, 2026

Lunai Bioworks Inc. (LNAI) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha

Jan 14, 2026

Jan 13, 2026

Lunai Bioworks : JP Morgan Healthcare ConferenceMedTech Showcase Presentation - marketscreener.com

Jan 13, 2026

Jan 11, 2026

Lunai Bioworks (NASDAQ:LNAI) Raised to “Hold” at Wall Street Zen - Defense World

Jan 11, 2026

Dec 18, 2025

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance - GuruFocus

Dec 18, 2025

Dec 17, 2025

Lunai Bioworks: Year-End Partnering Momentum & Stock Setup - International Business Times

Dec 17, 2025

Dec 09, 2025

Lunai bioworks identifies three parkinsons disease subtypes By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

Lunai bioworks identifies three parkinsons disease subtypes - Investing.com

Dec 09, 2025